Somnomed Ltd has released a press release.
500,000 patients treated worldwide
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Somnomed
- Core revenue growth up 9% in Q3
- S&P DJI Announces March 2019 Quarterly Rebalance
- Core revenue growth up 13% in Q2
- 2018 AGM addresses - Chairman and CEO
- Change in Leadership of SomnoMed
Later from Somnomed
- North American direct revenues up 31% in Q4
- Strong North American revenue growth in Q1
- Core revenue growth up 19% in Q2
- Half Year Accounts
- Pause in Trading
Follow Somnomed into a list and get an email when it puts out news.
Follow Somnomed